The increased production of immunoactive molecules during the first hours after stroke, induced by cerebral ischemia, triggers a release of pro-inflammatory cytokines, including tumor necrosis factor alpha (TNF-a) and IL-6, by activated immune cells, reflecting the peripheral immune response to stroke [17, 26]. The gene discussed is IL6; the disease is stroke disorder.